Last reviewed · How we verify

Topical Benzocaine 20% — Competitive Intelligence Brief

Topical Benzocaine 20% (Topical Benzocaine 20%) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Local anesthetic. Area: Anesthesia / Pain Management.

marketed Local anesthetic Voltage-gated sodium channels Anesthesia / Pain Management Small molecule Live · refreshed every 30 min

Target snapshot

Topical Benzocaine 20% (Topical Benzocaine 20%) — Nourhan M.Aly. Benzocaine is a local anesthetic that blocks sodium channels in nerve cell membranes, preventing the initiation and conduction of nerve impulses.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Topical Benzocaine 20% TARGET Topical Benzocaine 20% Nourhan M.Aly marketed Local anesthetic Voltage-gated sodium channels
ropivacaine plus clonidine ropivacaine plus clonidine University Hospital, Lille marketed Local anesthetic with adjuvant alpha-2 agonist Voltage-gated sodium channels (ropivacaine); alpha-2 adrenergic receptors (clonidine)
Ropivacine and Chloroprocaine mixture Ropivacine and Chloroprocaine mixture University of New Mexico marketed Local anesthetic combination Voltage-gated sodium channels
ropivacaine (Naropin) ropivacaine (Naropin) University of Zurich marketed Local anesthetic (amide) Voltage-gated sodium channels
ropivacaïne 0,5 % ropivacaïne 0,5 % Nantes University Hospital marketed Local anesthetic (amide) Voltage-gated sodium channels
Ropivicaine with Epinephrine Ropivicaine with Epinephrine Health Sciences North Research Institute marketed Local anesthetic with vasoconstrictor Voltage-gated sodium channels
ropivicaine 0.2% ropivicaine 0.2% University of Alabama at Birmingham marketed Local anesthetic (amide) Voltage-gated sodium channels

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Local anesthetic class)

  1. University of California, San Diego · 3 drugs in this class
  2. Durect · 3 drugs in this class
  3. Pacira Pharmaceuticals, Inc · 3 drugs in this class
  4. Wake Forest University Health Sciences · 3 drugs in this class
  5. Medical University of Vienna · 3 drugs in this class
  6. Imperial College London · 2 drugs in this class
  7. Hvidovre University Hospital · 2 drugs in this class
  8. Innocoll · 2 drugs in this class
  9. George Washington University · 2 drugs in this class
  10. Guy's and St Thomas' NHS Foundation Trust · 2 drugs in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Topical Benzocaine 20% — Competitive Intelligence Brief. https://druglandscape.com/ci/topical-benzocaine-20. Accessed 2026-05-18.

Build your own brief

Pick any drug + add comparators: